Drug data last refreshed 17h ago · AI intelligence enriched 1w ago
Zinc Sulfate is an intravenous solution containing zinc, an essential trace mineral used to prevent and treat zinc deficiency in patients unable to receive adequate zinc through oral intake or enteral nutrition. It is indicated for patients on total parenteral nutrition (TPN) or those with severe malabsorption or malnutrition. The drug works by replenishing depleted zinc stores necessary for immune function, wound healing, and protein synthesis.
Peak lifecycle suggests stable revenue and established market presence, with roles focused on maintaining hospital and institutional market penetration rather than aggressive growth expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Zinc Sulfate in Preventing Loss of Sense of Taste in Patients Undergoing Radiation Therapy for Head and Neck Cancer
Working on Zinc Sulfate positions you in the specialized institutional and parenteral nutrition market, leveraging deep healthcare provider relationships and clinical credibility rather than broad consumer or primary care exposure. This role builds expertise in hospital formulary management, critical care protocols, and specialty pharmacy partnerships—valuable for career progression in hospital-based pharmaceutical commercialization.
Worked on ZINC SULFATE at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.